Navigation Links
Usage Of Oral Contraceptives Need Not Be Feared By SLE Patients

In a research co headed by Jill Buyon, M.D., of New York’s Hospital for Joint Diseases said that oral contraceptives can be given to women with inactive or stable Systemic// Lupus Erythematosus (SLE) and they would not show symptoms of increased risk of flares of the disease.

This research was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH). In this disease the body fails to recognize as self and starts to attack its own tissues of the skin, joints and other internal organs.

Initially clinicians are very hesitant to give contraceptive pills (orally) to the patients with SLE because of the fear that they might show increased and unwanted disease activity.

This study which included 183 women with inactive or stable SLE were given oral contraceptives (triphasic 35 μg.ethinylestradiol/0.5-1 mg norethindrone for twelve 28-day cycles).they did not show any difference in reaction when compared to the controls who were given placebo.

Seven percent of the women showed severe reaction in both the test as well as in control categories. They suffered from various symptoms like new or worsening central nervous system involvement; inflammation of the blood vessels (vasculitis), kidneys (nephritis) and/or muscles (myositis); and/or blood problems, low platelet count (thrombocytopenia) and complete destruction of the red blood cells (hemolytic anemia).

Moderate reactions were seen in both the categories over the one year follow up session which includes fevers, inflammation of the skin, joints, pericarditis, and mucous membranes lining the nose and mouth.

This disease is very common among women. The ratio of women to men suffering from this disease is 10:1. Women usually suffer during the child bearing age when the female hormones are at its peak.

When experiments were conducted with mouse with SLE they showed increased reaction when administered with estrogen. They also affected the B cells which plays a vital role in the disease process.

According to this study it is clearly seen that women suffering with inactive or stable SLE can take estrogen without any fear of increased reaction due to the disease. But on the other hand women suffering from a risk of blood clots are not supposed to take oral contraceptives as estrogen increases blood clot formation.

Hence in conclusion this study has improved the quality of the life of people with rheumatic disease
'"/>




Related medicine news :

1. Usage of coil better in brain haemorrhage
2. Oxygen Usage During Exercise Could Indicate Heart Problems
3. The Usage Of Anti-Inflammatory Drugs Questioned
4. Drug Pramipexole Usage Linked To Gambling Addiction In Parkinsons Patients
5. Generic Drugs Usage In US Can Save $20 Billion – Express Script Surve
6. Safety Of Indian Sex Workers At Risk Due To Poor Condom Usage
7. Dummy Usage Raises Doubts.
8. More The Usage More The Growth In The Adult Brain.
9. Ignorance in the Usage of Pill Persists Among Many Women
10. Vaticans Council Reviews Condom Usage
11. Large Scale Free Access On Usage Of HIV Drugs Could Help In Fighting Its Spread
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology: